Guest guest Posted March 19, 2011 Report Share Posted March 19, 2011 Boooooo!!!!! (At least if tossed, it won't be "with prejudice." BUT "good enough" will not suffice. These cases need to be to-the-letter.)TerrySent via BlackBerry by AT&TFrom: "jeremy9282" <jeremybryce1953@...>Sender: SSRI medications Date: Sat, 19 Mar 2011 19:43:21 -0000<SSRI medications >Reply SSRI medications Subject: Judge mulls dismissing Glaxo lawyer indictment (Reuters) - A federal judge is considering whether to dismiss an indictment against a former GlaxoKline PLC (GSK.L) lawyer after new evidence emerged about possible prosecutorial errors in her indictment.The lawyer, s, was charged in November with obstructing a Food and Drug Administration probe into Glaxo's marketing of its antidepressant drug Wellbutrin.At a hearing on Thursday in Greenbelt, land, s' attorney asked U.S. District Judge Titus to throw out the indictment, arguing that prosecutors failed to properly answer a question raised by a grand juror about s' defense.The question concerned whether it was relevant that s received advice from others. s' defense lawyers have said she was acting on the advice of Glaxo's law firm, King & Spalding, a so-called advice-of-counsel defense."The problems here are fundamental, obvious and I don't think they can be defended," s' attorney, Reid Weingarten, said.At Thursday's hearing, Titus asked prosecutors pointed questions about how they responded to the grand jury request. "The question is whether the answer was correct, and if not, what's the remedy?" he asked.Titus did not say when he would issue a ruling, but raised the possibility of throwing out the current indictment while allowing prosecutors to start new grand jury proceedings and seek a new indictment. Jasperse, a lawyer for the government, said that prosecutors essentially fulfilled their duty before the grand jury and that it would be "extreme" to throw out the indictment."Could the answer have been more articulate and complete? Absolutely," Jasperse said. "But the government basically got it right."After the hearing, Weingarten and Jasperse declined to comment. King & Spalding spokesman Les Zuke declined to comment on the firm's role.Grand jury proceedings are typically secret, but some portions of this one were made public in court filings that were part of the defense's effort to dismiss the indictment.(Reporting by Carlyn Kolker of Reuters Legal; Editing by Eddie ) http://www.reuters.com/article/2011/03/17/glaxosmithkline-stevens-idUSN1726439120110317 Quote Link to comment Share on other sites More sharing options...
Guest guest Posted March 19, 2011 Report Share Posted March 19, 2011 Boooooo!!!!! (At least if tossed, it won't be "with prejudice." BUT "good enough" will not suffice. These cases need to be to-the-letter.)TerrySent via BlackBerry by AT&TFrom: "jeremy9282" <jeremybryce1953@...>Sender: SSRI medications Date: Sat, 19 Mar 2011 19:43:21 -0000<SSRI medications >Reply SSRI medications Subject: Judge mulls dismissing Glaxo lawyer indictment (Reuters) - A federal judge is considering whether to dismiss an indictment against a former GlaxoKline PLC (GSK.L) lawyer after new evidence emerged about possible prosecutorial errors in her indictment.The lawyer, s, was charged in November with obstructing a Food and Drug Administration probe into Glaxo's marketing of its antidepressant drug Wellbutrin.At a hearing on Thursday in Greenbelt, land, s' attorney asked U.S. District Judge Titus to throw out the indictment, arguing that prosecutors failed to properly answer a question raised by a grand juror about s' defense.The question concerned whether it was relevant that s received advice from others. s' defense lawyers have said she was acting on the advice of Glaxo's law firm, King & Spalding, a so-called advice-of-counsel defense."The problems here are fundamental, obvious and I don't think they can be defended," s' attorney, Reid Weingarten, said.At Thursday's hearing, Titus asked prosecutors pointed questions about how they responded to the grand jury request. "The question is whether the answer was correct, and if not, what's the remedy?" he asked.Titus did not say when he would issue a ruling, but raised the possibility of throwing out the current indictment while allowing prosecutors to start new grand jury proceedings and seek a new indictment. Jasperse, a lawyer for the government, said that prosecutors essentially fulfilled their duty before the grand jury and that it would be "extreme" to throw out the indictment."Could the answer have been more articulate and complete? Absolutely," Jasperse said. "But the government basically got it right."After the hearing, Weingarten and Jasperse declined to comment. King & Spalding spokesman Les Zuke declined to comment on the firm's role.Grand jury proceedings are typically secret, but some portions of this one were made public in court filings that were part of the defense's effort to dismiss the indictment.(Reporting by Carlyn Kolker of Reuters Legal; Editing by Eddie ) http://www.reuters.com/article/2011/03/17/glaxosmithkline-stevens-idUSN1726439120110317 Quote Link to comment Share on other sites More sharing options...
Guest guest Posted March 19, 2011 Report Share Posted March 19, 2011 Boooooo!!!!! (At least if tossed, it won't be "with prejudice." BUT "good enough" will not suffice. These cases need to be to-the-letter.)TerrySent via BlackBerry by AT&TFrom: "jeremy9282" <jeremybryce1953@...>Sender: SSRI medications Date: Sat, 19 Mar 2011 19:43:21 -0000<SSRI medications >Reply SSRI medications Subject: Judge mulls dismissing Glaxo lawyer indictment (Reuters) - A federal judge is considering whether to dismiss an indictment against a former GlaxoKline PLC (GSK.L) lawyer after new evidence emerged about possible prosecutorial errors in her indictment.The lawyer, s, was charged in November with obstructing a Food and Drug Administration probe into Glaxo's marketing of its antidepressant drug Wellbutrin.At a hearing on Thursday in Greenbelt, land, s' attorney asked U.S. District Judge Titus to throw out the indictment, arguing that prosecutors failed to properly answer a question raised by a grand juror about s' defense.The question concerned whether it was relevant that s received advice from others. s' defense lawyers have said she was acting on the advice of Glaxo's law firm, King & Spalding, a so-called advice-of-counsel defense."The problems here are fundamental, obvious and I don't think they can be defended," s' attorney, Reid Weingarten, said.At Thursday's hearing, Titus asked prosecutors pointed questions about how they responded to the grand jury request. "The question is whether the answer was correct, and if not, what's the remedy?" he asked.Titus did not say when he would issue a ruling, but raised the possibility of throwing out the current indictment while allowing prosecutors to start new grand jury proceedings and seek a new indictment. Jasperse, a lawyer for the government, said that prosecutors essentially fulfilled their duty before the grand jury and that it would be "extreme" to throw out the indictment."Could the answer have been more articulate and complete? Absolutely," Jasperse said. "But the government basically got it right."After the hearing, Weingarten and Jasperse declined to comment. King & Spalding spokesman Les Zuke declined to comment on the firm's role.Grand jury proceedings are typically secret, but some portions of this one were made public in court filings that were part of the defense's effort to dismiss the indictment.(Reporting by Carlyn Kolker of Reuters Legal; Editing by Eddie ) http://www.reuters.com/article/2011/03/17/glaxosmithkline-stevens-idUSN1726439120110317 Quote Link to comment Share on other sites More sharing options...
Guest guest Posted March 19, 2011 Report Share Posted March 19, 2011 Boooooo!!!!! (At least if tossed, it won't be "with prejudice." BUT "good enough" will not suffice. These cases need to be to-the-letter.)TerrySent via BlackBerry by AT&TFrom: "jeremy9282" <jeremybryce1953@...>Sender: SSRI medications Date: Sat, 19 Mar 2011 19:43:21 -0000<SSRI medications >Reply SSRI medications Subject: Judge mulls dismissing Glaxo lawyer indictment (Reuters) - A federal judge is considering whether to dismiss an indictment against a former GlaxoKline PLC (GSK.L) lawyer after new evidence emerged about possible prosecutorial errors in her indictment.The lawyer, s, was charged in November with obstructing a Food and Drug Administration probe into Glaxo's marketing of its antidepressant drug Wellbutrin.At a hearing on Thursday in Greenbelt, land, s' attorney asked U.S. District Judge Titus to throw out the indictment, arguing that prosecutors failed to properly answer a question raised by a grand juror about s' defense.The question concerned whether it was relevant that s received advice from others. s' defense lawyers have said she was acting on the advice of Glaxo's law firm, King & Spalding, a so-called advice-of-counsel defense."The problems here are fundamental, obvious and I don't think they can be defended," s' attorney, Reid Weingarten, said.At Thursday's hearing, Titus asked prosecutors pointed questions about how they responded to the grand jury request. "The question is whether the answer was correct, and if not, what's the remedy?" he asked.Titus did not say when he would issue a ruling, but raised the possibility of throwing out the current indictment while allowing prosecutors to start new grand jury proceedings and seek a new indictment. Jasperse, a lawyer for the government, said that prosecutors essentially fulfilled their duty before the grand jury and that it would be "extreme" to throw out the indictment."Could the answer have been more articulate and complete? Absolutely," Jasperse said. "But the government basically got it right."After the hearing, Weingarten and Jasperse declined to comment. King & Spalding spokesman Les Zuke declined to comment on the firm's role.Grand jury proceedings are typically secret, but some portions of this one were made public in court filings that were part of the defense's effort to dismiss the indictment.(Reporting by Carlyn Kolker of Reuters Legal; Editing by Eddie ) http://www.reuters.com/article/2011/03/17/glaxosmithkline-stevens-idUSN1726439120110317 Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.